Cholesterol interaction with the daunorubicin binding site of P-glycoprotein

Biochemical and Biophysical Research Communications

Volumn 276, Issue 3, 2000, Pages 909-916

  Wang, Er Jia ^a   Casciano, Christopher N ^a   Clement, Robert P ^a   Johnson, William W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cholesterol; MDR; P glycoprotein; Transport

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; CHOLESTEROL; COLCHICINE; CYCLOSPORIN A; DAUNORUBICIN; GLYCOPROTEIN P; MANNITOL; RHODAMINE 123; VERAPAMIL;

ANIMAL CELL; ARTICLE; BILIARY EXCRETION; CANCER CHEMOTHERAPY; CELL MEMBRANE TRANSPORT; DRUG BINDING SITE; DRUG PROTEIN BINDING; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HYDROLYSIS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0034610076     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3554     Document Type: Article

References (59)

1. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile
2. Biochemistry of multidrug resistance mediated by the multidrug transporter
3. The mouse multidrug resistance gene family: Structural and functional analysis
4. P-glycoprotein - A mediator of multidrug resistance in tumour cells
5. P-glycoprotein and multidrug resistance
6. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
7. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein
8. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833
9. Changes in biliary excretory mechanisms in rats with ethinyloestradiol-induced cholestasis
10. 3-Hydroxy-3-methylglutaryl-Coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats
11. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
12. Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice
13. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
14. Hepatobiliary transport
15. Tangier disease is caused by mutation in the gene encoding ATP-binding cassette transporter 1
16. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
17. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
18. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
19. Cholesterol homeostasis. Modulation by amphiphiles
20. Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: Possible role of P-glycoprotein
21. Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells
22. Role of multidrug resistance P-glycoproteins in cholesterol esterification
23. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol
24. Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles
25. MDR1 gene expression in normal and atherosclerotic human arteries
26. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein
27. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: Application to lens ATPases
28. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase
29. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells
30. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells
31. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis
32. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein
33. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
34. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein
35. Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency
36. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities
37. A general pattern for substrate recognition by P-glycoprotein
38. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells
39. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
40. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
41. The role of drug-lipid interactions in the biological activity of modulators of multidrug resistance
42. 2+ channel blockers to the membrane lipid bilayer
43. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: Implications in drug-resistance phenomena
44. Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties
45. Role of cell cholesterol in modulating vincristine uptake and resistance
46. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles
47. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter
48. Specific drug binding by purified lipid-reconstituted P-glycoprotein: Dependence on the lipid composition
49. Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein
50. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein
51. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane
52. Functional rafts in cell membranes
53. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
54. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains
55. Role of membranes in bile formation. Comparison of the composition of bile and liver bile-canalicular plasma membrane subfraction
56. Lipid fluidity of hepatocyte plasma membrane subfractions and their differential regulation by calcium
57. Fluidity and function of hepatocyte plasma membranes
58. Absorption and metabolism of dietary cholesterol